Xvivo Perfusion AB (publ) Stock Forecast

Xvivo Perfusion AB (publ) stock price up more than 14.80% on Wednesday
(Updated on Apr 24, 2024)

XVIVO.ST Signals & Forecast

The Xvivo Perfusion AB (publ) stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at kr327.64 and kr291.49. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 03, 2024, and so far it has risen 39.32%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Xvivo Perfusion AB (publ) stock

On the downside, the stock finds support just below today's level from accumulated volume at kr319.00 and kr289.00. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Xvivo Perfusion AB (publ) finds support just below today's level at kr319.00. If this is broken, then the next support from accumulated volume will be at kr289.00 and kr286.50.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved kr27.00 between high and low, or 7.68%. For the last week, the stock has had daily average volatility of 4.02%.

The Xvivo Perfusion AB (publ) stock is extremely overbought on RSI14 (83). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: kr356.19 (-3.34%) (This stock has high daily movements and this gives high risk. The RSI14 is 83 and this increases the risk substantially. There is a buy signal from a pivot bottom found 15 days ago.)

Trading Expectations (XVIVO.ST) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Xvivo Perfusion AB (publ) to open at kr366.17, and during the day (based on 14 day Average True Range), to move between kr353.62 and kr383.38, which gives a possible trading interval of +/-kr14.88 (+/-4.04%) up or down from last closing price. If Xvivo Perfusion AB (publ) takes out the full calculated possible swing range there will be an estimated 8.08% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ kr319.00, some kr49.50 (13.43%) from the current price of kr368.50, our system finds the risk reward attractive.

Is Xvivo Perfusion AB (publ) stock A Buy?

Xvivo Perfusion AB (publ) holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Xvivo Perfusion AB (publ) of Thursday, April 25, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.